[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Keurig Dr Pepper Inc. (KDP) filed a Form 144 indicating that the Robert J. Gamgort 1999 Trust intends to sell 208,000 common shares through Morgan Stanley Smith Barney on or about 29 Jul 2025. At an assumed market price of roughly $32.95 per share, the aggregate value is $6.86 million. KDP has ≈1.36 billion shares outstanding, so the proposed sale represents ≈0.015 % of total shares.

The trust—associated with KDP’s Executive Chairman Robert Gamgort—has already executed two sales under a Rule 10b5-1 trading plan within the past three months:

• 1 May 2025: 208,000 shares for $7.10 million
• 2 Jun 2025: 208,000 shares for $6.89 million

Combined with the new notice, the trust’s 3-month disposition totals 624,000 shares (≈0.046 % of KDP’s shares outstanding) for proceeds of roughly $20.8 million.

No purchase-price debt, material adverse information, or non-public information is indicated, and the filer affirms compliance with Rule 144 and 10b5-1 requirements. While the dollar amount is notable, the percentage of float is immaterial and does not, by itself, signal a shift in company fundamentals.

Positive

• None.

Negative

• Continued insider selling: Third 208 k-share disposal in three months could be viewed cautiously by some investors despite its small proportional size.

Insights

Securities Analyst

TL;DR: Insider trust plans to sell 208k KDP shares; small vs. float, neutral fundamental impact.

The filing flags incremental insider selling by Robert Gamgort’s trust. Even after three consecutive 208 k blocks, total disposals are <1 % of Gamgort’s reported holdings and <0.05 % of shares outstanding, limiting supply pressure. Sales occur under a 10b5-1 plan, reducing information-risk concerns. Unless a pattern accelerates or coincides with weak operating metrics, I view this as routine portfolio diversification rather than a bearish signal; therefore market impact is expected to be minimal.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Boughton Soleil

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	07/28/2025		S(1)		2,572	D	$58.7	155,593	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Remarks:

	/s/ Alexandra Cotter Wilkins, Attorney-in-Fact	07/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Keurig Dr Pepper (KDP) shares are being proposed for sale in this Form 144?

The notice covers 208,000 common shares.

What is the estimated market value of the shares to be sold?

Based on the filing, the aggregate value is about $6.86 million.

Who is selling the shares and under what plan?

The Robert J. Gamgort 1999 Trust is selling under a Rule 10b5-1 trading plan.

What proportion of KDP’s total shares does the proposed sale represent?

Approximately 0.015 % of the ≈1.36 billion shares outstanding.

Have there been other recent insider sales by the same trust?

Yes. The trust sold 208,000 shares on 1 May 2025 and 208,000 shares on 2 Jun 2025 for combined proceeds of ~$14 million.